| $385M | ||
| $350M | ||
| $215M | ||
| $94M | ||
| $82M | ||
| $62M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.
Over the last 12 months, insiders at Bright Minds Biosciences Inc. have bought $0 and sold $0 worth of Bright Minds Biosciences Inc. stock.
On average, over the past 5 years, insiders at Bright Minds Biosciences Inc. have bought $7.23M and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 184,331 shares for transaction amount of $4M was made by Cormorant Asset Management, LP (10 percent owner) on 2024‑11‑04.
| 2024-11-04 | Cormorant Asset Management, LP | 10 percent owner | 184,331 1.3083% | $21.70 | $4M | -28.71% | ||
| 2024-10-16 | Cormorant Asset Management, LP | 10 percent owner | 50,000 0.3836% | $23.46 | $1.17M | +25.14% | ||
| 2024-10-15 | Cormorant Asset Management, LP | 10 percent owner | 372,591 0.6743% | $5.53 | $2.06M | -6.46% |
| Cormorant Asset Management, LP | 10 percent owner | 1059331 13.6038% | $80.48M | 3 | 0 | <0.0001% |
$3,611,891 | 113 | 13.40% | $605.89M | |
$24,857,912 | 21 | -35.40% | $711.12M | |
$46,858,891 | 18 | -11.58% | $585.02M | |
$3,556,951 | 18 | 9.64% | $523.09M | |
$59,102,045 | 17 | 8.52% | $685.28M | |
$7,254,955 | 14 | 20.70% | $619.87M | |
$92,357,691 | 12 | 87.24% | $712.26M | |
$19,167,169 | 10 | 28.48% | $527.04M | |
$75,069,528 | 10 | 19.77% | $526.24M | |
$140,543,039 | 10 | 0.77% | $598.05M | |
$11,541,901 | 10 | 8.07% | $681.35M | |
$49,165,200 | 7 | 12.92% | $639.94M | |
$94,000,000 | 7 | -20.84% | $644.42M | |
$79,246,559 | 5 | -27.73% | $507.97M | |
$1,746,565 | 4 | -29.05% | $575.18M | |
$58,352 | 4 | -43.78% | $508.58M | |
$10,104,842 | 3 | 5.45% | $522.59M | |
Bright Minds Biosciences Inc. (DRUG) | $7,234,370 | 3 | -3.34% | $591.58M |
$3,850,000 | 1 | -51.32% | $522.94M |
| Increased Positions | 40 | +102.56% | 1M | +23.76% |
| Decreased Positions | 14 | -35.9% | 524,174 | -9.87% |
| New Positions | 16 | New | 593,267 | New |
| Sold Out Positions | 2 | Sold Out | 74,623 | Sold Out |
| Total Postitions | 65 | +66.67% | 6M | +13.89% |
| Janus Henderson Group Plc | $95,617.00 | 14.32% | 1.15M | 0 | 0% | 2025-09-30 |
| Cormorant Asset Management, Lp | $88,412.00 | 13.24% | 1.06M | 0 | 0% | 2025-09-30 |
| Vivo Capital, Llc | $41,865.00 | 6.27% | 501,617 | +250,045 | +99.39% | 2025-09-30 |
| Commodore Capital Lp | $41,730.00 | 6.25% | 500,000 | 0 | 0% | 2025-09-30 |
| Perceptive Advisors Llc | $37,498.00 | 5.62% | 449,290 | +28,600 | +6.8% | 2025-09-30 |
| Adage Capital Partners Gp, L.L.C. | $33,029.00 | 4.95% | 395,743 | +195,743 | +97.87% | 2025-09-30 |
| Braidwell Lp | $25,346.00 | 3.8% | 303,685 | +303,685 | New | 2025-09-30 |
| Blackrock, Inc. | $19,539.00 | 2.93% | 234,118 | +24,441 | +11.66% | 2025-09-30 |
| Morgan Stanley | $16,097.00 | 2.41% | 192,866 | +30,797 | +19% | 2025-09-30 |
| Sio Capital Management, Llc | $15,921.00 | 2.38% | 190,764 | -321,574 | -62.77% | 2025-09-30 |